Opto Sense
Opto Sense is an innovative company focused on advancing cancer diagnostics, particularly in breast cancer care. Their core technology revolves around the detection and real-time profiling of Circulating Tumor Cells (CTCs) using autofluorescence, microfluidics, optoelectronics, and machine learning. This enables personalized medicine by providing clinicians with real-time data to guide therapy choices. Their platform offers sensitive and specific CTC detection without the need for labeling, utilizing advanced signal processing and AI integration for continuous monitoring and analysis.
Opto Sense
Opto Sense is an innovative company focused on advancing cancer diagnostics, particularly in breast cancer care. Their core technology revolves around the detection and real-time profiling of Circulating Tumor Cells (CTCs) using autofluorescence, microfluidics, optoelectronics, and machine learning. This enables personalized medicine by providing clinicians with real-time data to guide therapy choices. Their platform offers sensitive and specific CTC detection without the need for labeling, utilizing advanced signal processing and AI integration for continuous monitoring and analysis.